Abstract
Lactoperoxidase (LPO) is a 78 kDa heme-containing oxidation–reduction enzyme present in milk, found in physiological fluids of mammals. LPO has an antimicrobial activity, and presumably contribute to the protective functions of milk against infectious diseases. In this study, recombinant vaccinia virus expressing bovine LPO (vv/bLPO) was constructed. In rabbit kidney (RK13) cells infected with vv/bLPO, recombinant bLPO was detected in both cell extracts and culture supernatants. Tunicamycin treatment decreased the molecular weight of recombinant bLPO, indicating that recombinant bLPO contains a N-linked glycosylation site. The replication of recombinant vaccinia viruses expressing bovine lactoferrin (vv/bLF) at a multiplicity of infection (moi) of 5 plaque-forming units (PFU)/cell was inhibited by antiviral activity of recombinant bLF, suggesting that vv/bLF has an antiviral effect against vaccinia virus. On the other hand, the replication of vv/bLPO at a moi of 5 PFU/cell was not inhibited by antiviral activity of recombinant bLPO, indicating that this recombinant virus could be used as a suitable viral vector. These results indicate that a combination of bLPO and vaccinia virus vector may be useful for medical and veterinary applications in vivo.
References
Buller RML, Smith GL, Cremer K, Notkins AL, Moss B (1985) Decreased virulence of recombinant vaccinia virus expression vectors is associated with thymidine kinase-negative phenotype. Nature (London) 317:813–815
Carlström A (1969) Lactoperoxidase. Identification of multiple molecular forms and their interrelationships. Acta Chem Scand 23:171–184
Chochola J, Yamaguchi Y, Moguilevsky N, Bollen A, Strosberg DA, Stanislawski M (1994) Virucidal effect of myeloperoxidase on human immunodeficiency virus type-1 infected cells. Antimicrob Agents Chemother 38:969–972
Dull TJ, Uyeda C, Strosberg AD, Nedwin G, Seilhamer JJ (1990) Molecular cloning of cDNA encoding bovine and human lactoperoxidase. DNA Cell Biol 9:499–509
El Messaoudi K, Verheyden AM, Thiry L, Fourez S, Tasiaux N, Bollen A, Moguilevsky N (2002) Human recombinant myeloperoxidase antiviral activity on cytomegalovirus. J Med Virol 66:218–223
Ertl HC, Xiang Z (1996) Novel vaccine approaches. J Immunol 156:3579–3582
Inui K, Barrett T, Kitching RP, Yamanouchi K (1995) Long-term immunity in cattle vaccinated with a recombinant rinderpest vaccine. Vet Res 137:669–670
Kerr SM, Smith GL (1989) Vaccinia virus encodes a polypeptide with DNA ligase activity. Nucleic Acids Res 17:9039–9050
Klebanoff SJ, Kazazi F (1995) Inactivation of human immunodeficiency virus type 1 by the amine oxidase-peroxidase system. J Clin Microbiol 33:2054–2057
Kohonen-Corish MR, Blanden RV, King NJ (1989) Induction of cell surface expression of HLA antigens by human IFN-gamma encoded by recombinant vaccinia virus. J Immunol 143:623–627
Mansson-Rahemtulla B, Rahemtulla F, Baldone DC, Pruitt KM, Hjerpe A (1988) Purification and characterization of human salivary peroxidase. Biochemistry 27:233–239
Moguilevsky N, Steens M, Thiriart C, Prieels JP, Thiry L, Bollen A (1992) Lethal oxidative damage to human immunodeficiency virus by human recombinant myeloperoxidase. FEBS Lett 302:209–212
Moss B (1990) Regulation of vaccinia virus transcription. Annu Rev Biochem 59:661–688
Moss B, Cooper N (1982) Genetic evidence for vaccinia virus-encoded DNA polymerase: isolation of phosphonoacetate-resistant enzyme from the cytoplasm of cells infected with mutant virus. J Virol 43:673–678
Nishikawa Y, Iwata A, Xuan X, Nagasawa H, Fujisaki K, Otsuka H, Mikami T (2000) Expression of canine interferon-β by a recombinant vaccinia virus. FEBS Lett 466:179–182
Nishikawa Y, Iwata A, Katsumata A, Xuan X, Nagasawa H, Igarashi I, Fujisaki K, Otsuka H, Mikami T (2001) Expression of canine interferon-γ by a recombinant vaccinia virus and its antiviral effect. Virus Res 75:113–121
Odajima T, Onishi M, Hayama E, Motoji N, Momose Y, Shigematsu A (1996) Cytolysis of B-16 melanoma tumor cells mediated by the myeloperoxidase and lactoperoxidase systems. Biol Chem 377:689–693
Shin K, Hayasawa H, Lönnerdal B (2001) Inhibition of Escherichia coli respiratory enzymes by the lactoperoxidase-hydrogen peroxidase-thiocyanate antimicrobial system. J Appl Microbiol 90:489–493
Shin K, Wakabayashi H, Yamauchi K, Teraguchi S, Tamura Y, Kurokawa M, Shiraki K (2005) Effects of orally administered bovine lactoferrin and lactoperoxidase on influenza virus infection in mice. J Med Microbiol 54:717–723
Shuman S, Moss B (1987) Identification of a vaccinia virus gene encoding a type I DNA topoisomerase. Proc Natl Acad Sci USA 84:7478–7482
Stanislawski M, Rousseau V, Goavec M, Ito H (1989) Immunotoxins containing glucose oxidase and lactoperoxidase with tumoricidal properties: in vitro killing effectiveness in a mouse plasmacytoma cell model. Cancer Res 49:5497–5540
Tanaka T, Nakamura I, Lee NY, Kumura H, Shimazaki K (2003a) Expression of bovine lactoferrin and lactoferrin N-lobe by recombinant baculovirus and its antimicrobial activity against Prototheca zopfii. Biochem Cell Biol 81:349–354
Tanaka T, Sato S, Kumura H, Shimazaki K (2003b) Expression and characterization of bovine lactoperoxidase by recombinant baculovirus. Biosci Biotechnol Biochem 67:2254–2261
Tanaka T, Murakami S, Kumura H, Igarashi I, Shimazaki K (2006) Parasiticidal activity of bovine lactoperoxidase against Toxoplasma gondii. Biochem Cell Biol 84:774–779
Tsukiyama K, Yoshikawa Y, Kamata H, Imaoka K, Asano K, Funahashi S, Maruyama T, Shida H, Sugimoto M, Yamanouchi K (1989) Development of heat-stable recombinant rinderpest vaccine. Arch Virol 107:225–235
Watanabe S, Varsalona F, Yoo YC, Guillaume JP, Bollen A, Shimazaki K, Moguilevsky N (1998) Recombinant bovine lactoperoxidase as a tool to study the heme environment in mammalian peroxidases. FEBS Lett 441:476–479
Watanabe S, Murata S, Kumura H, Nakamura S, Bollen A, Moguilevsky N, Shimazaki K (2000) Bovine lactoperoxidase and its recombinant: comparison of structure and some biochemical properties. Biochem Biophys Res Commun 274:756–761
Yamamoto K, Miyoshi-Koshio T, Utsuki Y, Mizuno S, Suzuki K (1991) Virucidal activity and viral protein modification by myeloperoxidase: a candidate for defense factor of human polymorphonuclear leukocytes against influenza virus infection. J Infect Dis 164:8–14
Yasuda A, Kimura-Kuroda J, Ogimoto M, Miyamoto M, Sata T, Sato T, Takamura C, Kurata T, Kojima A, Yasui K (1990) Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus. J Virol 64:2788–2795
Acknowledgments
This work was supported by grants from the Hokuto Foundation. The first author is supported by Postdoctoral Fellowships for Research Abroad of the Japan Society for the Promotion of Science.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tanaka, T., Xuan, X., Kojima, A. et al. Expression and characterization of bovine lactoperoxidase by recombinant vaccinia virus. Cytotechnology 58, 127–133 (2008). https://doi.org/10.1007/s10616-009-9181-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-009-9181-4